Nils Elander

Publications

2023

Mustafa Asowed, Nils Elander, Linn Pettersson, Maria Ekholm, Dimitrios Papantoniou (2023) Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer BMC Cancer, Vol. 23, Article 309 Continue to DOI

2022

Sander Ellegård, Kristina Engvall, Mustafa Asowed, Anna-Lotta Hallbeck, Nils Elander, Olle Stål (2022) Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study Frontiers in Oncology, Vol. 12, Article 861324 Continue to DOI

2020

Ylva Naeser, Hildur Helgadottir, Yvonne Brandberg, Johan Hansson, Roger Olofsson Bagge, Nils Elander, Christian Ingvar, Karolin Isaksson, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Olga del Val Munoz, Antonis Valachis, Malin Jansson, Charlotte Sparring, Lars Ohlsson, Ulf Dyrke, Dimitrios Papantoniou, Anders Sundin, Gustav J. Ullenhag (2020) TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma BMC Cancer, Vol. 20, Article 1197 Continue to DOI

Hakon Blomstrand, Henrik Green, Mats Fredrikson, Emma Gransmark, Bergthor Björnsson, Nils Elander (2020) Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel BMC Cancer, Vol. 20, Article 950 Continue to DOI

Bergthor Björnsson, Carl Borrebaeck, Nils Elander, Thomas Gasslander, Danuta Gawel, Mika Gustafsson, Rebecka Jornsten, Eun Jung Jung Lee, Xinxiu Li, Sandra Lilja, David Martinez, Andreas Matussek, Per Sandström, Samuel Schäfer, Margaretha Stenmarker, Xiao-Feng Sun, Oleg Sysoev, Huan Zhang, Mikael Benson (2020) Digital twins to personalize medicine Genome Medicine, Vol. 12, Article 4 Continue to DOI